CEBPA Mutation Detection
2004247
Ordering Recommendation
Initial test for prognostication of CN-AML.
Mnemonic
CEBPA MUT
Methodology
Polymerase Chain Reaction/Sequencing
Performed
DNA isolation: Sun-Sat
Assay:
Mon, Wed, Fri
Reported
12-14 days  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Lavender (EDTA) OR bone marrow (EDTA).  
Specimen Preparation
Transport 5 mL whole blood (Min: 1 mL) OR 3 mL bone marrow (Min: 1 mL).  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Serum or plasma. Frozen or clotted specimens. Specimens collected in anticoagulants other than EDTA. Severely hemolyzed specimens.  
Remarks
  
Stability
Ambient: 24 hours; Refrigerated: 5 days; Frozen: Unacceptable  
Reference Interval
   
Interpretive Data
Refer to report.

See Compliance Statement B: www.aruplab.com/CS  
Note
 
CPT Code(s)
81403
Components
Component Test Code*Component Chart Name
2004249CEBPA Mutation Detection Results
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • CCAAT Enhancer Binding Protein Alpha
  • CEBP Alpha
  • CEBPA Mutation Analysis